Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene

Blood

Volumn 89, Issue 12, 1997, Pages 4628-4635

  Arcasoy, Murat O ^b   Degar, Barbara A ^b   Harris, Kevin W ^b   Forget, Bernard G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; DNA; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; INTERLEUKIN 3; METHYLCELLULOSE; NUCLEOTIDE; PEPTIDE; RECOMBINANT ERYTHROPOIETIN; RNA;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLONY FORMATION; CONTROLLED STUDY; DNA REPLICATION; DNA SEQUENCE; DOSE RESPONSE; ELECTROPHORESIS; ERYTHROCYTOSIS; EXON; FAMILIAL DISEASE; FEMALE; GENE; GENE DELETION; GENE MUTATION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PHLEBOTOMY; POLYCYTHEMIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030986297     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4628     Document Type: Article

References (38)

1. Spivak JL: Erythrocytosis, in Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE (eds): Hematology, Basic Principles and Practice (ed 2). New York, NY, Churchill-Livingstone, 1995, p 484
2. Adamson JW: Familial polycythemia. Semin Hematol 12:383, 1975
3. Prchal JT, Sokol L: "Benign erythrocytosis" and other familial and congenital polycythemias. Eur J Haematol 57:263, 1996
4. Prchal JT, Crist WM, Goldwasser E, Perrine G, Prchal JF: Autosomal dominant polycythemia. Blood 66:1208, 1985
5. Juvonen E, Ikkala E, Fyhrquist F, Ruutu T: Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 78:3066, 1991
6. Emanuel PD, Eaves CJ, Broudy VC, Moore MR, D'Andrea AD, Prchal JF, Eaves AC, Prchal JT: Hereditary polycythemia in three unrelated families. Blood 79:3019, 1992
7. de la Chapelle A, Träskelin A-L, Juvonen E: Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci USA 90:4495, 1993
8. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT: Primary familial polycythemia: A frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 86:15, 1995
9. Kralovics R, Tze L, Guan Y, Indrak K, Berman B, Sokol L, Prchal JT: Two unique EPOR mutations associated with primary familial and congenital polycythemias. Blood 86:18a, 1995 (abstr, suppl 1)
10. Kralovics R, Sokol L, Tze L, Guan Y, Prchal JF, Prchal JT: Absence of polycythemia phenotype in a child in PFCP family with Epo receptor mutation. Blood 86:18a, 1995 (abstr, suppl 1)
11. Furukawa T, Sakaue M, Otsuka T, Narita M, Koike T, Kishi K, Utsumi H, Aizawa Y: Primary familial polycythemia associated with novel point mutation in the erythropoietin receptor. Blood 88:145a, 1996 (abstr, suppl 1)
12. Gregg XT, Prchal JT: Erythropoietin receptor mutations and human disease. Semin Hematol 34:70, 1997
13. Gonda TJ, D'Andrea RJ: Activating mutations in cytokine receptors: Implications for receptor function and role in disease. Blood 89:355, 1997
14. Prchal JT, Semenza GL, Prchal J, Sokol L: Familial polycythemia. Science 268:1831,1995
15. 220/216). Blood 78:517, 1991
16. Kiyabu MT, Shibata D, Arnheim N, Martin WJ, Fitzgibbons PL: Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol 13:221, 1989
17. Noguchi CT, Bae KS, Chin K, Wada Y, Schechter AN, Hankins WD: Cloning of the human erythropoietin receptor gene. Blood 78:2548, 1991
18. de La Chapelle A, Sistonen P, Lehväslaiho H, Ikkala E, Juvonen E: Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341:82, 1993
19. Greenberger JS, Sakakeeny MA, Humphries RK, Eaves CJ, Eckner RJ: Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci USA 80:2931, 1983
20. Migliaccio G, Migliaccio AR, Kreider BL, Rovera G, Adamson JW: Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol 109:833, 1989
21. Harris KW, Mitchell RA, Winkelmann JC: Ligand binding properties of the human erythropoietin receptor extracellular domain expressed in Escherichia coli. J Biol Chem 267:15205, 1992
22. Penny LA, Forget, BG: Genomic organization of the human erythropoietin receptor gene. Genomics 11:974, 1991
23. Sokol L, Prchal JT: Two microsatellite repeat polymorphisms in the EPO gene. Hum Mol Genet 3:219, 1994
24. Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J: Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: One high-affinity and one low-affinity interaction. Biochemistry 35:1681, 1996
25. Krawczak M, Cooper DN: Gene deletions causing human genetic disease: Mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 86:425, 1991
26. Damen JE, Krosl J, Humphries K, Krystal G: The hyperresponsiveness of cells expressing truncated erythropoietin receptors is contingent upon insulin-like growth factor-1 in fetal calf serum. Blood 88:55a, 1996 (abstr, suppl 1)
27. Nakamura Y, Komatsu N, Nakauchi H: A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257:1138, 1992
28. Nakamura Y, Nakauchi H: A truncated erythropoietin receptor and cell death: A reanalysis. Science 264:588, 1994
29. Zhuang H, Niu Z, He T-C, Patel SV, Wojchowski DM: Erythropoietin-dependent inhibition of apoptosis is supported by carboxyltruncated receptor forms and blocked by dominant-negative forms of Jak2. J Biol Chem 270:14500, 1995
30. Yoshimura A, Longmore G, Lodish HF: Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647, 1990
31. D'Andrea AD, Yoshimura A, Youssoufian H, Zon LI, Koo J-W, Lodish HF: The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol Cell Biol 11:1980, 1991
32. Klingmüller U, Lorenz U, Cantley LC, Neel BG, Lodish HF: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729, 1995
33. Yi T, Zhang J, Miura O, Ihle JN: Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: Identification of potential binding sites. Blood 85:87, 1995
34. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
35. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N: Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84:1501, 1994
36. Ihle JN: Cytokine receptor signalling. Nature 377:591, 1995
37. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR: Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445, 1993
38. Arcasoy MO, Harris KW, Degar BA, Forget BG: Prolonged STAT5 activity associated with a naturally occurring truncation mutation of the human erythropoietin receptor. Blood 88:53a, 1996 (abstr, suppl 1)